INVA PEER ANALYSIS

Innoviva Inc — metric-by-metric comparison with peers and the industry median

INVAInnoviva Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

INVAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	INVA	TLX	MSB	CSL	RTALB	Ind. Median
P/E	3.67●	—	—	30.02	4.89	17.81
P/B	1.38	6.56	—	2.24	0.61●	3.49
EV/EBITDA	2.45●	123.31	—	10.37	74.61	14.92
P/S	4.37	3.34	31.91	2.67●	6.67	10.89

Financial Health
Metric	INVA	TLX	MSB	CSL	RTALB	Ind. Median
Current Ratio	21.13●	1.43	—	2.57	1.21	5.90
Debt/Equity	24.7%	112.3%	—	67.4%	1.2%●	10.9%
NetDebt/EBITDA	-0.44●	13.13	—	2.22	0.90	1.15

Profitability
Metric	INVA	TLX	MSB	CSL	RTALB	Ind. Median
Net Margin	118.9%	-0.9%	-115.3%	9.2%	136.3%●	-125.7%
ROE	50.7%●	-1.8%	-11.3%	7.7%	15.1%	-47.5%
ROA	32.6%●	-0.7%	-8.6%	3.8%	13.1%	-35.8%
EBITDA Margin	150.9%●	3.0%	-76.6%	32.8%	9.0%	-105.8%

Growth + Dividend
Metric	INVA	TLX	MSB	CSL	RTALB	Ind. Median
Rev. Growth	13.6%	56.3%	410.4%●	4.8%	24.0%	5.1%
NI Growth	—	—	—	-39.4%	134.0%●	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.0%	0.2%
Payout	—	—	0.0%	103.1%	0.0%	0.0%

Valuation
Metric	INVA	TYRA	SNDX	URGN	ZYME	ANAB	Ind. Median
P/E	3.67	—	—	—	—	—	17.81
P/B	1.38	4.92	45.95	-15.11●	11.57	140.25	3.49
EV/EBITDA	2.45●	—	—	—	—	30.41	14.92
P/S	4.37●	—	8.81	13.36	23.28	7.69	10.89

Financial Health
Metric	INVA	TYRA	SNDX	URGN	ZYME	ANAB	Ind. Median
Current Ratio	21.13●	20.49	5.47	4.69	10.82	7.58	5.90
Debt/Equity	24.7%	1.5%	829.8%	-158.6%●	10.4%	2,175.8%	10.9%
NetDebt/EBITDA	-0.44	2.89	0.04	-0.48●	3.69	-0.16	1.15

Profitability
Metric	INVA	TYRA	SNDX	URGN	ZYME	ANAB	Ind. Median
Net Margin	118.9%●	—	-112.0%	-94.8%	-126.3%	-11.5%	-125.7%
ROE	50.7%●	-36.9%	-189.5%	—	-42.0%	-114.6%	-47.5%
ROA	32.6%●	-34.7%	-43.7%	-53.2%	-22.7%	-7.1%	-35.8%
EBITDA Margin	150.9%●	—	-74.8%	-82.4%	-116.1%	25.2%	-105.8%

Growth + Dividend
Metric	INVA	TYRA	SNDX	URGN	ZYME	ANAB	Ind. Median
Rev. Growth	13.6%	-100.0%	396.7%●	52.9%	-13.0%	107.7%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on INVA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.